Cargando…
Phytosterols and Cardiovascular Disease
PURPOSE OF REVIEW: Coronary heart disease is the leading cause of mortality worldwide. Elevated blood cholesterol levels are not only the major but also the best modifiable cardiovascular risk factor. Lifestyle modifications which include a healthy diet are the cornerstone of lipid-lowering therapy....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410723/ https://www.ncbi.nlm.nih.gov/pubmed/34468867 http://dx.doi.org/10.1007/s11883-021-00964-x |
_version_ | 1783747160003575808 |
---|---|
author | Makhmudova, Umidakhon Schulze, P. Christian Lütjohann, Dieter Weingärtner, Oliver |
author_facet | Makhmudova, Umidakhon Schulze, P. Christian Lütjohann, Dieter Weingärtner, Oliver |
author_sort | Makhmudova, Umidakhon |
collection | PubMed |
description | PURPOSE OF REVIEW: Coronary heart disease is the leading cause of mortality worldwide. Elevated blood cholesterol levels are not only the major but also the best modifiable cardiovascular risk factor. Lifestyle modifications which include a healthy diet are the cornerstone of lipid-lowering therapy. So-called functional foods supplemented with plant sterols lower blood cholesterol levels by about 10–15%. RECENT FINDINGS: In the recent revision of the ESC/EAS dyslipidemia guideline 2019, plant sterols are recommended for the first time as an adjunct to lifestyle modification to lower blood cholesterol levels. However, the German Cardiac Society (DGK) is more critical of food supplementation with plant sterols and calls for randomized controlled trials investigating hard cardiovascular outcomes. An increasing body of evidence suggests that plant sterols per se are atherogenic. SUMMARY: This review discusses this controversy based on findings from in vitro and in vivo studies, clinical trials, and genetic evidence. |
format | Online Article Text |
id | pubmed-8410723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-84107232021-09-22 Phytosterols and Cardiovascular Disease Makhmudova, Umidakhon Schulze, P. Christian Lütjohann, Dieter Weingärtner, Oliver Curr Atheroscler Rep Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors) PURPOSE OF REVIEW: Coronary heart disease is the leading cause of mortality worldwide. Elevated blood cholesterol levels are not only the major but also the best modifiable cardiovascular risk factor. Lifestyle modifications which include a healthy diet are the cornerstone of lipid-lowering therapy. So-called functional foods supplemented with plant sterols lower blood cholesterol levels by about 10–15%. RECENT FINDINGS: In the recent revision of the ESC/EAS dyslipidemia guideline 2019, plant sterols are recommended for the first time as an adjunct to lifestyle modification to lower blood cholesterol levels. However, the German Cardiac Society (DGK) is more critical of food supplementation with plant sterols and calls for randomized controlled trials investigating hard cardiovascular outcomes. An increasing body of evidence suggests that plant sterols per se are atherogenic. SUMMARY: This review discusses this controversy based on findings from in vitro and in vivo studies, clinical trials, and genetic evidence. Springer US 2021-09-01 2021 /pmc/articles/PMC8410723/ /pubmed/34468867 http://dx.doi.org/10.1007/s11883-021-00964-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors) Makhmudova, Umidakhon Schulze, P. Christian Lütjohann, Dieter Weingärtner, Oliver Phytosterols and Cardiovascular Disease |
title | Phytosterols and Cardiovascular Disease |
title_full | Phytosterols and Cardiovascular Disease |
title_fullStr | Phytosterols and Cardiovascular Disease |
title_full_unstemmed | Phytosterols and Cardiovascular Disease |
title_short | Phytosterols and Cardiovascular Disease |
title_sort | phytosterols and cardiovascular disease |
topic | Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410723/ https://www.ncbi.nlm.nih.gov/pubmed/34468867 http://dx.doi.org/10.1007/s11883-021-00964-x |
work_keys_str_mv | AT makhmudovaumidakhon phytosterolsandcardiovasculardisease AT schulzepchristian phytosterolsandcardiovasculardisease AT lutjohanndieter phytosterolsandcardiovasculardisease AT weingartneroliver phytosterolsandcardiovasculardisease |